Health Sciences

Why is CBD oil everywhere?

From body balms to cocktails, CBD oil has exploded on the market, despite a lack of clinical trials and wildly different dosages among products. Marcel Bonn-Miller explains the science behind the fad.

Tina Rodia

25 years of integration, innovation, and ideals

2018 marked 25 years since the University of Pennsylvania Health System (UPHS) was first established—a milestone that would undoubtedly make the institution’s founder, Benjamin Franklin, proud.

Penn Today Staff

Energizing the immune system to eat cancer

An Abramson Cancer Center study identifies a method of priming macrophages to boost an anti-tumor response wherein macrophages attack and eat cancer cells.

Penn Today Staff

Using fat cells to predict response to anti-diabetes drugs

In a new study, a team of researchers have demonstrated—using fat cells derived from human stem cells—that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals.

Penn Today Staff



In the News


U.S. News & World Report

What is syphilis, and why are rates rising?

Amy Forrestel of the Perelman School of Medicine spoke about the symptoms, spread, and long-term effects of syphilis. If left untreated, the sexually transmitted infection “can wreak a lot of havoc” on the body, said Forrestel.

FULL STORY →



The Washington Post

A smarter way to think about willpower

Angela Duckworth of the School of Arts and Sciences and Katherine Milkman of the Wharton School are among co-authors of an op-ed about self-control. While many believe Americans’ willpower is on the decline, the authors write, “the scant scientific evidence on the question suggests that if anything, the capacity to delay gratification may be increasing.”

FULL STORY →



NPR

First U.S. patients treated with CRISPR as human gene-editing trials get underway

A clinical trial led by Edward Stadtmauer of the Perelman School of Medicine will be using CRISPR to treat cancer patients.

FULL STORY →



Associated Press

Senior’s weakness for scams may be warning sign of dementia

Jason Karlawish of the Perelman School of Medicine said a recent study on aging and scam awareness doesn’t prove a link between susceptibility and cognitive decline in seniors. However, Karlawish says, the results “should be a call to action to health care systems, the financial services industry and their regulators.”

FULL STORY →



The Washington Post

New cancer therapies offer great hope, but there can be surprising complications

Ravi Parikh of the Perelman School of Medicine spoke about rapid advances in cancer therapies. While excited about the possibilities, Parikh notes that new treatments come with new side effects, among other complications.

FULL STORY →